1. OWE-033 Integrating major haemorrhage policies: endoscopy and laboratory working together. (8th June 2018) Authors: Dwyer, Julie; Murray, Audrey; Law, Lisa; MacDonald, Lesley; Hazra, Eleanor; Whyte, Suzanne; Hands, Katherine; Barron, Morag; Groome, Max Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PWE-045 Vedolizumab results in reduced hospitalisation and steroid use over 1-year:results from the scottish vedolizumab cohort. (8th June 2018) Authors: Plevris, Nikolas; Chuah, Cher; Jenkinson, Phil; Allen, R; Baker, P; Brennan, Paul; Churchhouse, Antonia; Din, S; Donoghue, Emma; Gaya, Daniel; Groome, Max; Jafferbhoy, H; Jones, G; Macdonald, Jonathan; MacMaster, Morag; Mowat, Craig; Naismith, G; Noble, C; Potts, L; Saffouri, E Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P43 Real-world experience of subcutaneous vedolizumab for treatment of IBD in NHS tayside. (19th June 2022) Authors: McLean, Mairi; Cartlidge, Peter; Fyall, Julie; Paterson, Jacqueline; Groome, Max; Mowat, Craig; McLean, Mairi H Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗